tris-(1,10-phenanthroline)ruthenium has been researched along with Alzheimer Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhat, SS; Jani, V; Joshi, B; Joshi, RR; Kulkarni, PP; Kumbhar, AS; Ramteke, SN; Sonawane, UB; Vyas, NA | 1 |
1 other study(ies) available for tris-(1,10-phenanthroline)ruthenium and Alzheimer Disease
| Article | Year |
|---|---|
Ruthenium(II) polypyridyl complex as inhibitor of acetylcholinesterase and Aβ aggregation.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Cell Line, Tumor; Cholinesterase Inhibitors; Coordination Complexes; Humans; Organometallic Compounds; Phenanthrolines; Pyridines; Ruthenium | 2014 |